<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Contrarian Stock Market Investing News - Featuring Bargain Stocks &#187; Pharmaceuticals Industry</title>
	<atom:link href="http://www.contrarianprofits.com/articles/tag/pharmaceuticals-industry/feed" rel="self" type="application/rss+xml" />
	<link>http://www.contrarianprofits.com</link>
	<description>Access market-beating ideas from the world&#039;s top investment gurus on stock market investing, the gold market, ETFs, Forex trading and real estate values.</description>
	<lastBuildDate>Mon, 10 May 2010 15:10:45 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Europe Stocks Rise as Buoyant Pharmas Offset Miners</title>
		<link>http://www.contrarianprofits.com/articles/europe-stocks-rise-as-buoyant-pharmas-offset-miners/9311</link>
		<comments>http://www.contrarianprofits.com/articles/europe-stocks-rise-as-buoyant-pharmas-offset-miners/9311#comments</comments>
		<pubDate>Fri, 28 Nov 2008 19:54:20 +0000</pubDate>
		<dc:creator>Contrarian Profits</dc:creator>
				<category><![CDATA[Financial News]]></category>
		<category><![CDATA[ALO]]></category>
		<category><![CDATA[BMW]]></category>
		<category><![CDATA[BP]]></category>
		<category><![CDATA[deflation]]></category>
		<category><![CDATA[Energy Firms]]></category>
		<category><![CDATA[Europe Stocks]]></category>
		<category><![CDATA[European Shares]]></category>
		<category><![CDATA[European Stocks]]></category>
		<category><![CDATA[FP]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Industrial Sectors]]></category>
		<category><![CDATA[Market Rally]]></category>
		<category><![CDATA[mining stocks]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[pharma stocks]]></category>
		<category><![CDATA[Pharmaceuticals Industry]]></category>
		<category><![CDATA[RNO]]></category>
		<category><![CDATA[SI]]></category>
		<category><![CDATA[SNY]]></category>
		<category><![CDATA[VLKAY]]></category>
		<category><![CDATA[XTA]]></category>

		<guid isPermaLink="false">http://www.contrarianprofits.com/?p=9311</guid>
		<description><![CDATA[<p>FTSEurofirst 300 up 1.1 pct on the day, up 13 pct on week&#8230; Index lost 7 pct in Nov, ninth month of losses in 2008&#8230; Cyclicals hammered; defensive pharmas surge </p>
<p> </p>
<p> European stocks ended higher on Friday, as buoyant pharmaceutical shares eclipsed a drop in cyclical mining and industrial sectors hit by renewed economic fears, while energy shares tumbled along with oil. </p>
<p> The FTSEurofirst 300 index of top European shares  closed 1.1 percent higher at 862.07 points. </p>
<p> Although it gained 13 percent during the week, the index dropped 7 percent in November, recording a ninth month of losses in what has been a torrid 2008 for equities worldwide. </p>
<p> Pharma stocks made strong gains on Friday, with  <a href="http://finance.google.com/finance?q=LON:GSK">GlaxoSmithKline</a> up 5.1 percent and <a href="http://finance.google.com/finance?q=NYSE:SNY">Sanofi-Aventis</a> up&#8230;</p>]]></description>
			<content:encoded><![CDATA[<p>FTSEurofirst 300 up 1.1 pct on the day, up 13 pct on week&#8230; Index lost 7 pct in Nov, ninth month of losses in 2008&#8230; Cyclicals hammered; defensive pharmas surge <span id="more-9311"></span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> European stocks ended higher on Friday, as buoyant pharmaceutical shares eclipsed a drop in cyclical mining and industrial sectors hit by renewed economic fears, while energy shares tumbled along with oil. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> The FTSEurofirst 300 index of top European shares  closed 1.1 percent higher at 862.07 points. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> Although it gained 13 percent during the week, the index dropped 7 percent in November, recording a ninth month of losses in what has been a torrid 2008 for equities worldwide. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> Pharma stocks made strong gains on Friday, with  <a href="http://finance.google.com/finance?q=LON:GSK">GlaxoSmithKline</a> up 5.1 percent and <a href="http://finance.google.com/finance?q=NYSE:SNY">Sanofi-Aventis</a> up 4.5 percent. <a href="http://finance.google.com/finance?q=NYSE:NVS">Novartis </a>, whose CEO said the company could increase its dividend and also resume share buybacks once it has reduced its debt, gained 4.4 percent. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> The sector rallied after the publication of a long-anticipated EU report on generic competition. Although Competition Commissioner Neelie Kroes said preliminary results showed competition in the pharmaceuticals industry &#8220;does not work as well as it should&#8221;, traders said the absence of specific penalties in the report brought some relief to pharma stocks. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> Energy firms such as <a href="http://finance.google.com/finance?q=EPA:FP">Total </a>and <a href="http://finance.google.com/finance?q=BP+">BP </a>dropped  0.7-2.6 percent as oil prices  sank below $52 a barrel on  signs OPEC would defer cutting production when it meets this  weekend in Cairo. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> Industrials were also among the biggest losers, with <a href="http://finance.google.com/finance?q=NYSE:SI">Siemens </a>down 3.8 percent and <a href="http://finance.google.com/finance?q=Alstom+">Alstom </a>down 6 percent. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> Despite the market&#8217;s recovery during the week, analysts  remain wary about a potential &#8220;Christmas rally&#8221; this year. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> &#8220;The volatility is not about to come down immediately. The economic newsflow is just too horrible. It&#8217;s too early to call for a straight market rally at this point,&#8221; said Arthur van Slooten, strategist at Societe Generale, in Paris. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> &#8220;With deflation fears, risky assets have been pricing in the worst. But it doesn&#8217;t mean that all of a sudden, from now on you have a straight way up. We know that the newsflow will be terrible, but we need at least some sort of indication that the bottom is maybe in sight,&#8221; he said. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> &#8220;Next year&#8217;s first quarter will really look awful in terms of macro data and with analyst further downgrading their estimates and companies finally becoming realistic in their own guidance. That in itself could provide us with a sound basis to build from there.&#8221; </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> Miners took a beating on Friday, adding to recent sharp  losses. <a href="http://finance.google.com/finance?q=LON:AAL">Anglo American</a> shed 2.4 percent and <a href="http://finance.google.com/finance?q=Xstrata+">Xstrata </a>dropped 3 percent. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> Prices for copper, a key industrial metal, slipped as tumbling industrial production data from Japan highlighted bleak prospects for demand in an oversupplied market, while prices for aluminium also fell, hit by the rising fears about the health of the embattled auto sector. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> &#8220;There is little doubt that the outlook for metals demand is grim for at least the next few quarters and prices have fallen to levels that reflect market expectations for further stock increases,&#8221; Barclays Capital said in a note. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> Automakers lost ground, with <a href="http://finance.google.com/finance?q=OTC%3AVLKAY">Volkswagen </a>down 5  percent, BMW  off 3.4 percent and <a href="http://finance.google.com/finance?q=EPA%3ARNO">Renault </a>down 4.8 percent. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> &#8220;Going into the weekend, one can&#8217;t help but worry that we are only a heartbeat away from the next scare story,&#8221; said Chris Hossain, senior sales manager at ODL Securities. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> &#8220;The markets appear to have been buoyed by the feeling that the U.S. will be bailing out the auto industry, but one has to wonder how much more the global governments can continue to support troubled industries,&#8221; he added. </span></p>
<p><span style="font-size: x-small; font-family: arial,helvetica;"> Around Europe, Germany&#8217;s DAX index eked out a gain of 0.1 percent, UK&#8217;s FTSE 100 index rose 1.5 percent and France&#8217;s CAC 40 added 0.4 percent. </span></p>
<p>By Blaise Robinson<br />
PARIS, Nov 28 (Reuters)</p>
]]></content:encoded>
			<wfw:commentRss>http://www.contrarianprofits.com/articles/europe-stocks-rise-as-buoyant-pharmas-offset-miners/9311/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.176 seconds -->

